Oral kontraseptif kullanan kadınlarda inflamatuvar belirteçlerinin ve adezyon moleküllerinin değişimi
Öz
Amaç: Bu çalışmanın amacı, oral kontraseptiflerin adezyon moleküllerinin serum seviyelerine olan etkisini araştırarak, sentetik östrojenlerin ateroskleroza karşı koruyucu etkisi olup olmadığı saptamaktır.
Gereç ve Yöntem: Ek hastalığı bulunmayan, kontrasepsiyon amaçlı en az 3 aydır oral kontraseptif kullanan, 18-45 yaş aralığında olan hastaların serum interlökin 6 (İL-6), tümör nekrozis faktör alfa (TNF alfa), damarsal hücre yapışma molekülü 1 (VCAM-1), hücreler arası adezyon molekülü (ICAM-1), E selektin, P selektin, c reaktif protein (CRP) seviyeleri ve eritrosit sedimentasyon hızları (ESH); ek hastalığı bulunmayan, düzenli adet gören, 18-45 yaş aralığında olan sağlıklı gönüllülerle karşılaştırıldı.
Bulgular: Her iki grubun VCAM-1, ICAM-1, E selektin, P selektin, TNF alfa, İL 6, ESH seviyeleri arasında anlamlı fark saptanmadı. Oral kontraseptif kullanan grupta serum CRP seviyeleri anlamlı olarak daha yüksek saptandı.
Sonuç: Oral kontraseptiflerin adezyon moleküllerinin serum seviyelerini değiştirdiği gösterilemiştir. Serum crp seviyelerinin değişimleri ise karaciğer ilk geçiş etkisine bağlanmaktadır.
Anahtar Kelimeler
Kaynakça
- 1. Nofer JR. Estrogens and atherosclerosis: insights from animal models and cell systems. Journal of Molecular Endocrinology 2012; 48(2):13-29.2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program- Adult treatment Panel 3, İnternational Diabetes Federation, and Worl Health Organization Definitions of the metabolic syndrome as predictors of incident cardiovascular diseas and diabetes. Diabetes care 2007; 30(1):8-13. 3. Kaseta Jr, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular diseas in the diabetic woman. J Clin Endocrinol Metab 1999;84(6):1835-38.4. Libby P. The moleculer bases of acute coronary syndromes. Circulation. 1995;91(11): 2844-50.5. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003; 91(3):3–6.6. Souter I, Janzen C, Martinez Maza O, Breen EC, Stanczyk F, Chaudhuri G, et al. Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives comparede with normally menstruating women: Implications in atherosclerosis. Fertility and Sterility 2005;83(5):1480-8.7. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circulation Research 1999;85(4):377– 85.8. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, et al. Effect of postmenopausal hormones on inflammation sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999; 100(7) :717–22.9. Jilma B, Hildebrandt J, Kapiotis S, Wagner OF, Kitzweger E, Mullner C, et al. Effects of estradiol on circulating P-selectin. J Clin Endo Metab 1996;81(6):2350 –5.10. Souter I, Huang A, Martinez-Maza O, Breen EC, Decherney AH, Chaudhuri G, et al. Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-a, and interleukin-6 in in vitro fertilization cycles. Fertility and Sterility 2009;91(5), 2012–9.11. Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MR. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women; cross-sectional study. Contraception 2012;86(5):506-10.12. Tatsumi H, Kitawaki J, Tanaka K, Hosoda T, Honjo H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 2002;42(4):287-94.13. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T, et al. Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 2001;21(2):243-8.14. Raman K, Chong M, Akhtar-Danesh GG, D'Mello M, Hasso R, Ross S, et al. Genetic markers of inflammation and their role in cardiovascular disease.Can J Cardiol 2013;29(1):67-74.15. van Rooijen M, Hansson LO, Frostegård J, Silveira A, Hamsten A, Bremme K. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost 2006;4(1):77-82.16. Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on c-reactive protein, other serum markers of ınflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702-10
